NSEAnalysts/Institutional Investor Meet/Con. Call Updates3d ago · 16 Oct 2026, 08:21 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Beta Drugs Limited · BETA
✦ AI SummaryResults
Beta Drugs Limited has informed the Exchange about an upcoming earnings conference call to discuss Operational and Financial performance Q2 & H1 FY27 on Thursday, 22nd October, 2026 at 4:00 P.M. (IST).
Analysis Scores
Earnings Impact8/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact9/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Beta Drugs Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
BETA_16102026202108_Concall_Intimation.pdf
View document text
BDL/PKL/SEC/2026-27
16th October, 2026
National Stock Exchange of India Ltd.
Exchange Plaza, 5th Floor
Plot no. C/l, G Block
Bandra-Kurla Complex, Bandra (E)
Mumbai — 400 051.
SYMBOL-BETA
Sub.: Earnings conference call to discuss Operational and Financial performance Q2 & H1
FY27.
Dear Sir,
Pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing
Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that
the Management of our Company will be hosting an Earnings conference call to discuss
Operational and Financial performance Q2 & H1 FY27 on Thursday, 22nd October, 2026 at
4:00 P.M. (IST).
We are enclosing herewith the invitation to the conference call for reference.
Thanking You
Your’s faithfully
For Beta Drugs Ltd.
Rajni Brar
Company Secretary
Conference Call Invitation
Q2 & H1FY27 Earnings Call
PRIVATE CLIENT GROUP
PhillipCapital (India) Private Limited cordially invites you to participate in
Beta Drugs Ltd.
Q2 & H1FY27 Earnings conference call to discuss operational and financial performance
Speakers NSE: BETA | INE351Y01019
Mr. Rahul Batra – Chairman & Managing Director
Bloomberg: BETADR IN
Mr. Nipun Arora – Chief Financial Officer
Mr. Ashutosh Shukla – Director (Sales & Marketing)
Call Leader Thursday – 22nd October 2026 @ 04:00 PM IST
Mr. Apurva Shah / Mr. Srisurya Kalagarla 06:30 PM Singapore & HK / 11:30 AM UK
Pre-register to avoid wait time, join with DiamondPass Click Here to register
Dial-In-Numbers
Primary Number: +91 22 6280 1143/+91 22 7115 8044
The numbers listed above is universally accessible from all networks and all countries.
Toll Free Number: USA: 18667462133 / UK: 08081011573 / Singapore: 8001012045 / Hong Kong: 800964448
#PhillipCapital (India) Private Limited remains committed to adhere to all regulatory guidelines and follow the best governance and transparency practices. Therefore:
• The proceedings of this call will be recorded.
• The list and full details of participants on the call will be shared by us with the corporate. Participants are expected to provide true and legitimate details.
• All necessary disclosures on Stock Exchanges (including call invite intimation, recording details & call transcript) is expected to be complied by the respective corporate.